產(chǎn)品中心
當(dāng)前位置:首頁 > 產(chǎn)品中心 > 氣體濃度控制 > 動(dòng)物低氧濃度控制實(shí)驗(yàn)艙 > ProOx-100動(dòng)物間歇低氧實(shí)驗(yàn)系統(tǒng)
簡要描述:塔望科技提供全系列的動(dòng)物實(shí)驗(yàn)用低/高氧控制產(chǎn)品,包括恒定濃度控制的低氧動(dòng)物箱、高氧動(dòng)物箱、可編程的間歇氧濃度控制系統(tǒng)、帶緩沖艙的手套低氧箱等。整套間歇氧氧實(shí)驗(yàn)箱裝置主要由氧氣控制器和動(dòng)物實(shí)驗(yàn)箱兩部分組成。另可提供多種不同的氣體控制器,滿足不同實(shí)驗(yàn)O2、CO2、NO、CO、O3等氣體濃度控制的需求。
詳細(xì)介紹
品牌 | 其他品牌 | 產(chǎn)地類別 | 國產(chǎn) |
---|---|---|---|
應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,生物產(chǎn)業(yè),制藥 |
產(chǎn)品描述
塔望科技提供全系列的動(dòng)物實(shí)驗(yàn)用低/高氧控制產(chǎn)品,包括恒定濃度控制的低氧動(dòng)物箱、高氧動(dòng)物箱、可編程的間歇氧濃度控制系統(tǒng)、帶緩沖艙的手套低氧箱等。整套間歇氧氧實(shí)驗(yàn)箱裝置主要由氧氣控制器和動(dòng)物實(shí)驗(yàn)箱兩部分組成。另可提供多種不同的氣體控制器,滿足不同實(shí)驗(yàn)O2、CO2、NO、CO、O3等氣體濃度控制的需求。
ProOx-100動(dòng)物間歇低氧實(shí)驗(yàn)系統(tǒng)可以控制動(dòng)物實(shí)驗(yàn)箱內(nèi)持續(xù)低氧的環(huán)境,用以制造相關(guān)的間歇低氧實(shí)驗(yàn)?zāi)P?。用戶可自由設(shè)置所需要的濃度和實(shí)驗(yàn)持續(xù)時(shí)間,所有的設(shè)置通過控制主機(jī)觸摸屏完成,人性化設(shè)計(jì),操作簡便。
ProOx-100動(dòng)物間歇低氧實(shí)驗(yàn)系統(tǒng)監(jiān)測(cè)指標(biāo)全面,動(dòng)物低氧艙內(nèi)具有集成化的傳感器模塊,內(nèi)置溫度、濕度、氧氣、二氧化碳傳感器??梢詫?shí)時(shí)監(jiān)測(cè)動(dòng)物低氧艙內(nèi)的環(huán)境。系統(tǒng)通過閉環(huán)反饋控制,根據(jù)動(dòng)物低氧艙內(nèi)的氧濃度實(shí)時(shí)反饋控制,使動(dòng)物實(shí)驗(yàn)數(shù)據(jù)更準(zhǔn)確。Ox-100動(dòng)物低氧實(shí)驗(yàn)系統(tǒng)具有優(yōu)良的控制性能,持續(xù)低氧實(shí)驗(yàn)時(shí),氧濃度的誤差為0.1%。
如需高氧實(shí)驗(yàn),請(qǐng)選擇型號(hào)Ox-100HE。
產(chǎn)品特點(diǎn)及參數(shù)
1. 為動(dòng)物間歇低氧實(shí)驗(yàn)?zāi)P偷慕⑻峁┓€(wěn)定的低氧環(huán)境
2. 按照設(shè)定氣體濃度自動(dòng)配比氣體,無需在箱體外混合比例氣體,實(shí)驗(yàn)氧濃度的準(zhǔn)確,節(jié)省氣源
3. 艙體采用全透明PMMA材質(zhì),防止由于光線影響動(dòng)物生物節(jié)律
4. 7英寸大屏觸摸屏控制,人性化界面,操作簡單
5. 監(jiān)測(cè)參數(shù):溫度、濕度、氧氣O2濃度、二氧化碳濃度
6. 控制精度:±0.1%
7. 非色散紅外(NDIR)二氧化碳傳感器,測(cè)量范圍:0~5000ppm
8. 進(jìn)口電化學(xué)氧氣O2濃度檢測(cè)器,測(cè)量范圍:0-25%vol,線性度好,檢測(cè)準(zhǔn)確、使用壽命長。具有溫度補(bǔ)償機(jī)制
9. 溫度檢測(cè):進(jìn)口高精度溫度傳感器
10. 氧氣濃度變化動(dòng)態(tài)曲線,直觀了解氧氣濃度變化的過程
11. 具有定時(shí)功能,實(shí)驗(yàn)完成,自動(dòng)恢復(fù)常氧狀態(tài),并伴有聲音提示
12. 氧氣濃度自動(dòng)校準(zhǔn):通過控制器對(duì)傳感器快速校準(zhǔn)
13. *的氣體混合及循環(huán)機(jī)制,保證箱體內(nèi)氣體濃度的均一
14. 高性能電磁閥,性能穩(wěn)定,超長壽命
15. 艙體尺寸有多種選擇,可靈活搭配。也可根據(jù)實(shí)驗(yàn)要求進(jìn)行定制
ProOx-100動(dòng)物間歇低氧實(shí)驗(yàn)系統(tǒng)多功能控制
可進(jìn)行間歇低氧實(shí)驗(yàn)(CIH)、急性缺氧實(shí)驗(yàn)、慢性缺氧實(shí)驗(yàn)、高氧/低氧交替實(shí)驗(yàn)
應(yīng)用領(lǐng)域
肺動(dòng)脈高壓、腎臟疾病研究、腫瘤研究、心血管疾病研究、視網(wǎng)膜病變、運(yùn)動(dòng)醫(yī)學(xué)研究、OSAHS、腦發(fā)育與神經(jīng)生物學(xué)、干細(xì)胞研究、醫(yī)學(xué)研究等
型號(hào)說明
名稱 | 型號(hào) | 說明 | 單位 |
動(dòng)物低氧實(shí)驗(yàn)系統(tǒng) | Ox-100 | 恒定氧控制,低氧 | 套 |
動(dòng)物氧濃度實(shí)驗(yàn)系統(tǒng) | Ox-100HE | 恒定氧控制,低氧/高氧 | 套 |
動(dòng)物間歇低氧實(shí)驗(yàn)系統(tǒng) | ProOx-100 | 恒定氧控制/間歇氧控制,低氧 | 套 |
動(dòng)物間歇氧濃度實(shí)驗(yàn)系統(tǒng) | ProOx-100HE | 恒定氧控制/間歇氧控制,低氧/高氧 | 套 |
動(dòng)物間歇低氧實(shí)驗(yàn)系統(tǒng) | ProOx-100-CIH | 專用于睡眠呼吸暫停造模 | 套 |
艙體型號(hào)(可選擇不同尺寸的低氧艙)
名稱 | 型號(hào) | 說明 | 單位 |
動(dòng)物實(shí)驗(yàn)艙體小號(hào) | OxC-S | 大鼠籠x1 | 臺(tái) |
動(dòng)物實(shí)驗(yàn)艙體中號(hào) | OxC-M | 大鼠籠x2 | 臺(tái) |
動(dòng)物實(shí)驗(yàn)艙體大號(hào) | OxC-L | 大鼠籠x4 | 臺(tái) |
動(dòng)物實(shí)驗(yàn)艙體特大號(hào) | OxC-XL | 大鼠籠x8 | 臺(tái) |
動(dòng)物實(shí)驗(yàn)艙體-CIH | OxC-CIH | 36只小鼠 | 臺(tái) |
手套操作箱 | Gl-700 | 700L | 臺(tái) |
引用文獻(xiàn)
[1]Ma Jinqiu,Wang Chenyun,Sun Yunbo,Pang Lulu,Zhu Siqing,Liu Yijing,Zhu Lin,Zhang Shouguo,Wang Lin,Du Lina. "Comparative study of oral and intranasal puerarin for prevention of brain injury induced by acute high-altitude hypoxia" . [J] International Journal of Pharmaceutics,2020,591
?[2]Guijuan Chen,Kang Cheng,Yun Niu,Li Zhu,Xueting Wang."Epicatechin gallate prevents inflammatory response in hypoxia-activated microglia and cerebral edema by inhibiting NF-κB signaling" . [J]. Archives of Biochemistry and Biophysics ,Volume 729, 109393;
[3]Yapeng,LuPanpanChang,WangwangDing,JiangpeiBian,DanWang,XuetingWang,QianqianLuo,XiaomeiWu,LiZhu."Pharmacological inhibition of mitochondrial division attenuates simulated high-altitude exposure-induced cerebral edema in mice: Involvement of inhibition of the NF-κB signaling pathway in glial cells". [J]. European Journal of Pharmacology,Volume 929,2022,175137
[4]Jun-Yu Wei, Miao-Yue Hu, Xiu-Qi Chen, Feng-Ying Lei, Jin-Shuang Wei, Jie Chen, Xuan-Kai Qin & Yuan-Han Qin ."Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner" . [J]. European Journal of Pharmacology,Renal Failure, 44:1, 2056-2065
[5]Yilan Wang, Zherui Shen, Caixia Pei, Sijing Zhao, Nan Jia, Demei Huang, Xiaomin Wang, Yongcan Wu, Shihua Shi, Yacong He, Zhenxing Wang,"Eleutheroside B ameliorated high altitude pulmonary edema by attenuating ferroptosis and necroptosis through Nrf2-antioxidant response signaling" . [J]. Biomedicine & Pharmacotherapy, Volume 156, 2022,113982
[6]Fang Zhao, Yan Meng, Yue Wang, Siqi Fan, Yu Liu,Xiangfeng Zhang, Chenyang Ran, Hongxin Wang and Meili Lu. "Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway" . [J]. Frontiers in Pharmacology,10.3389/fphar.2022.920977
[7]Xu Y, Kong X, Li J, Cui T, Wei Y, Xu J, Zhu Y , Zhu X. “Mild Hypoxia Enhances the Expression of HIF and VEGF and Triggers the Response to Injury in Rat Kidneys." [J]. Front. Physiol. 12:690496. doi: 10.3389/fphys.2021.690496
[8]Liang Xie, Qinhan Wu, Weiping Hu, Xu Wu, Guiling Xiang, Shengyu Hao, Han Guo, Shanqun Li. “Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions." [J]. Psychopharmacology.
[9]Li Huang, Tianyou Li, Min Zhou, Mengyan Deng, Lidong Zhang, Long Yi, Jundong Zhu, Xiaohui Zhu, Mantian Mi. “Hypoxia Improves Endurance Performance by Enhancing Short Chain Fatty Acids Production via Gut Microbiota Remodeling." [J]. Front. Microbiol. 12:820691
[10]Yanhong Pei a b, Lifei Huang c, Tong Wang c, Qinhan Yao a, Yanrong Sun a, Yan Zhang a, Xiaomei Yang a, Jiliang Zhai d, Lihua Qin a, Jiajia Xue c, Xing Wang c, Hongquan Zhang a b, Junhao Yan."Bone marrow mesenchymal stem cells loaded into hydrogel/nanofiber composite scaffolds ameliorate ischemic brain injury. materialstoday ADVANCES, Volume 17, March 2023, 100349.
[11]Zhang, C., Sun, Y., Guo, Y. et al. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension. “[J].Cell Death Discov. 9, 98 (2023).
[12]Chenyu Xu, Jun Xu, Chunfang Zou, Qian Li, Shan Mao, Ying Shi, Yan Tan, Wei Gu, Liang Ye. "Chronic Intermittent Hypoxia Regulates CaMKII-Dependent MAPK Signaling to Promote the Initiation of Abdominal Aortic Aneurysm." [J]. Hindawi, Oxidative Medicine and Cellular Longevity Volume 2021, Article ID 2502324, 15 pages
[13]Jing Zhang, Jian-Zhong Jiang, Jun Xu, Chen-Yu Xu, Shan Mao, Ying Shi, Wei Gu, Chun-Fang Zou, Yue-Ming Zhao, Liang Ye. "Identification of Novel Biomarkers for Abdominal Aortic Aneurysm Promoted by Obstructive Sleep Apnea." [J]. Elsevier Inc. This is an open access article under the CC BY-NC-ND license
[14]Zhang Q, Xu L, Bai Y, Chen P, Xing M, Cai F, Wu Y, Song W. “Intermittent hypoxia-induced enhancement of sociability and working memory associates with CNTNAP2 upregulation." [J]. Front. Mol. Neurosci. 16:1155047.
[15]Chen Zhang, Yue Sun, Yingying Guo, Jingjing Xu, Haiyan Zhao. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension." [J]. Cell Death Discovery (2023) 9:98.
MFN2-mediated mitochondrial fusion facilitates acute hypobaric hypoxia-induced cardiac dysfunction by increasing glucose catabolism and ROS production,Biochimica et Biophysica Acta (BBA) - General Subjects,Volume 1867, Issue 9,2023,130413,ISSN 0304-4165
[17]Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr. etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 …N Jia, Z Shen, S Zhao, Y Wang, C Pei, D Huang… - International …, 2023 - Elsevier… The rats were placed in a hypobaric hypoxia chamber (ProOx-830, Tow-Int Tech, Shanghai,China) to mimic the environment of high-altitude hypobaric hypoxic. After the rats were …
[18]Nan Jia, Zherui Shen, Sijing Zhao, Yilan Wang, Caixia Pei, Demei Huang, Xiaomin Wang, Yongcan Wu, Shihua Shi, Yacong He, Zhenxing Wang,Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway,International Immunopharmacology,Volume 121,2023,110423,ISSN 1567-5769
[19]AUTHOR=Long Yanrong, Chen Hongbin, Deng Junchao, Ning Junjie, Yang Pengbo, Qiao Lina, Cao Zhongwei ,TITLE=Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice ,JOURNAL=Frontiers in Pharmacology VOLUME=13 YEAR=2022 DOI=10.3389/fphar.2022.1039103 ,The chamber contained a continuous oxygen monitoring system (ProOX-100HE, TOW-INTTECH)
[20]Haimei Lun, Ruochuan Liu, Qiao Hu, Yaoli Liu, Lisi Wei, Xia Liu, Dan Wu, Shangyong Zhu,Contrast?Enhanced?Ultrasonography?of?Kidney?in?Chronic?Intermittent?Hypoxia?Rat?Model,[J]Journal of Ultrasound in Medicine,2022-12-07 ,DOI:10.1002/jum.16147
*我公司可提供3Q驗(yàn)證,根據(jù)客戶的特殊應(yīng)用、特殊需求提供功能定制服務(wù),也可以提供相關(guān)的實(shí)驗(yàn)服務(wù),詳情請(qǐng)來電問詢。
產(chǎn)品咨詢